Alerts will be sent to your verified email
Verify Email
QUESTLAB
|
Quest Laboratories
|
Sotac Pharmaceutical
|
Kimia Biosciences
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
27.48 % | -2.41 % | -335.15 % |
|
5yr average Equity Multiplier
|
2.66 | 5.52 | 66.02 |
|
5yr Average Asset Turnover Ratio
|
1.38 | 1.27 | 1.14 |
|
5yr Avg Net Profit Margin
|
8.5 % | 3.04 % | -0.67 % |
|
Price to Book
|
1.57 | 2.69 | 12.0 |
|
P/E
|
10.39 | 17.83 | 14.51 |
|
5yr Avg Cash Conversion Cycle
|
100.68 Days | 57.86 Days | -33.97 Days |
|
Inventory Days
|
35.64 Days | 44.94 Days | 101.63 Days |
|
Days Receivable
|
95.62 Days | 113.65 Days | 98.68 Days |
|
Days Payable
|
124.41 Days | 123.13 Days | 171.28 Days |
|
5yr Average Interest Coverage Ratio
|
15.83 | 3.95 | 0.78 |
|
5yr Avg ROCE
|
36.4 % | 21.68 % | 10.6 % |
|
5yr Avg Operating Profit Margin
|
12.5 % | 8.59 % | 3.89 % |
|
5 yr average Debt to Equity
|
0.33 | 2.1 | 29.85 |
|
5yr CAGR Net Profit
|
83.07 % | n/a | 13.51 % |
|
5yr Average Return on Assets
|
10.79 % | 3.18 % | -0.69 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
66.78 % | 72.85 % | 74.94 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.95 % | 0.0 | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Quest Laboratories
|
Sotac Pharmaceutical
|
Kimia Biosciences
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|